lenvatinib Mesylate
Catalog No.
C6375
Featured Products
Lenvatinib mesylate (E7080 mesylate) is an orally available small-molecule tyrosine kinase inhibitor that simultaneously targets multiple tyrosine kinases, including vascular endothelial growth factor receptors (VEGFR1-3), fibroblast growth factor receptors (FGFR1-4), platelet-derived growth factor receptor (PDGFR), stem cell factor receptor (KIT), and rearranged during transfection (RET). This compound is commonly used to study the effects of signaling pathways mediated by the above receptors on tumor cell proliferation, angiogenesis, and tumor progression, and is widely applied in the field of cancer drug research.
| Storage | Store at -20°C |
| M.Wt | 522.96 |
| Cas No. | 857890-39-2 |
| Formula | C22H23ClN4O7S |
| Solubility | ≥12.53 mg/mL in DMSO with ultrasonic; insoluble in EtOH; insoluble in H2O |
| Chemical Name | 4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide methanesulfonate |
| SDF | Download SDF |
| Canonical SMILES | NC(C1=C(OC)C=C(N=CC=C2OC3=CC(Cl)=C(NC(NC4CC4)=O)C=C3)C2=C1)=O.OS(=O)(C)=O |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
Chemical structure
